Takashi Dejima

Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers — Japan

Medicine · Health Sciences

14h-index815citations45works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(11), Prostate Cancer Diagnosis and Treatment(9), Hormonal and reproductive studies(9), Bladder and Urothelial Cancer Treatments(8), RNA modifications and cancer(5)

Publications45 total

Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single‐center prospective randomized controlled trial (<scp>VAPOR TRIAL</scp>)
LUTS Lower Urinary Tract Symptoms·2024· 1 citedOpen Access
A prospective, single‐center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180‐W <scp>GreenLight XPS</scp> laser, a 300‐W diode laser, and a 200‐W thulium laser for the treatment of benign prostatic hyperplasia
LUTS Lower Urinary Tract Symptoms·2022· 9 cited
<scp>GreenLight HPS</scp> laser <scp>120 W</scp> vs diode laser <scp>300 W</scp> vaporization of the prostate for the treatment of benign prostatic hyperplasia in Japanese patients: A prospective, single‐center, randomized clinical trial
LUTS Lower Urinary Tract Symptoms·2020· 9 cited
Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants
Cancer Science·2018· 26 citedOpen Access
LIM-SH3 domain protein 1 promotes tumorgenesis in prostate cancer
European Urology Supplements·2018
<scp>SEMA</scp> 3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1
EMBO Molecular Medicine·2018· 95 citedOpen Access
Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer
Anticancer Research·2017· 2 citedOpen Access
The Association of Polymorphisms in the Gene Encoding Gonadotropin-Releasing Hormone with Serum Testosterone Level during Androgen Deprivation Therapy and Prognosis of Metastatic Prostate Cancer
The Journal of Urology·2017· 18 cited
The association of polymorphism in gonadotropin releasing hormone with serum testosterone level during androgen-deprivation therapy and prognosis in metastatic prostate cancer.
Journal of Clinical Oncology·2017
MP88-10 INHIBITION OF LIM AND SH3 DOMAIN PROTEIN 1 DELAYS CISPLATIN-RESISTANT BLADDER TUMOR PROGRESSION
The Journal of Urology·2017
Inhibition of LIM-SH3 domain protein 1 (LASP1) augments the anti-cancer effect of cisplatin in bladder cancer
European Urology Supplements·2017
Inhibition of semaphorin 3C augments the anti-cancer effect of sunitinib in renal cancer
European Urology Supplements·2017
Protein kinase C regulates Twist1 expression via NF-κB in prostate cancer
Endocrine Related Cancer·2017· 10 cited
The Differential Impact of Body Mass Index and the Feature of Metabolic Syndrome on Oncological Outcomes Following Different Surgical Procedures in Japanese Men with Prostate Cancer
Annals of Surgical Oncology·2016· 14 cited
Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression
The Prostate·2016· 15 cited
Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor
The Journal of Urology·2016· 69 cited
Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer
International Immunopharmacology·2016· 23 cited
MP66-11 LIM-SH3 DOMAIN PROTEIN 1 CORRELATES WITH CELL INVASION AND STEMNESS IN PROSTATE CANCER AND EARLY METASTASIS AFTER RADICAL PROSTATECTOMY
The Journal of Urology·2016Open Access
42 Targeting clusterin-associated proteins improve cellular sensitivity to taxane in prostate cancer
European Urology Supplements·2016
The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism
Prostate Cancer and Prostatic Diseases·2016· 29 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Ario Takeuchi(26), Masaki Shiota(20), Masatoshi Eto(19), Katsunori Tatsugami(16), Akira Yokomizo(15), Eiji Kashiwagi(15), Junichi Inokuchi(15), Seiji Naito(12), Martin Gleave(10), Keijiro Kiyoshima(9), Hisakata Yamada(7), Yasunobu Yoshikai(7), Kevin J. Tam(7), Tabitha Tombe(6), Takeshi Uchiumi(6), Kensuke Shibata(5), Choon Kiat Ong(5), YooHyun Song(4), Kenjiro Imada(4), Jeffrey Leong(4)